Abstract | OBJECTIVE: MATERIALS AND METHODS: RESULTS: We found no significant difference in successful outcome (p = 1.00), major complications (p = 1.00), duration of therapy (p = 0.21), or total rt-PA dose (p = 0.67) between those who received eptifibatide and those who did not during thrombolytic therapy. However, those patients who received an intraarterial loading dose of eptifibatide required substantially less rt-PA (9.0 +/- 4.4 mg vs 38.9 +/- 30.7 mg) to achieve successful thrombolysis. CONCLUSION: The adjunctive use of a GP IIb/IIIa platelet receptor inhibitor during thrombolysis for arterial occlusions may decrease the total dose of rt-PA required for thrombolysis without compromising success or complication rates. A prospective randomized study is needed to confirm that inhibitors of the GP IIb/IIIa platelet receptor can facilitate thrombolytic therapy in patients with acute lower extremity arterial occlusions.
|
Authors | Hyo-Chun Yoon, Franklin J Miller Jr |
Journal | AJR. American journal of roentgenology
(AJR Am J Roentgenol)
Vol. 178
Issue 3
Pg. 617-22
(Mar 2002)
ISSN: 0361-803X [Print] United States |
PMID | 11856686
(Publication Type: Journal Article)
|
Chemical References |
- Fibrinolytic Agents
- Peptides
- Platelet Aggregation Inhibitors
- Platelet Glycoprotein GPIIb-IIIa Complex
- Heparin
- Plasminogen Activators
- Tissue Plasminogen Activator
- Eptifibatide
|
Topics |
- Acute Disease
- Adult
- Aged
- Aged, 80 and over
- Arterial Occlusive Diseases
(drug therapy)
- Eptifibatide
- Female
- Fibrinolytic Agents
(therapeutic use)
- Graft Occlusion, Vascular
- Heparin
(adverse effects, therapeutic use)
- Humans
- Leg
(blood supply)
- Male
- Middle Aged
- Peptides
(adverse effects, therapeutic use)
- Plasminogen Activators
(therapeutic use)
- Platelet Aggregation Inhibitors
(therapeutic use)
- Platelet Glycoprotein GPIIb-IIIa Complex
(antagonists & inhibitors)
- Retrospective Studies
- Thrombolytic Therapy
(adverse effects)
- Thrombosis
(drug therapy)
- Tissue Plasminogen Activator
(adverse effects, therapeutic use)
|